Page last updated: 2024-08-26

sr141716 and cannabidiol

sr141716 has been researched along with cannabidiol in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (5.41)	18.2507
2000's	17 (45.95)	29.6817
2010's	16 (43.24)	24.3611
2020's	2 (5.41)	2.80

Authors

Authors	Studies
Bianchi, A; Cruciani, G; Fichera, M; Musumarra, G	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Carrillo-Salinas, FJ; Fernández-Ruiz, J; Franco, R; Gómez-Cañas, M; Goya, P; Guaza, C; Hurst, DP; Jagerovic, N; Lagartera, L; Morales, P; Navarro, G; Pazos, R; Reggio, PH	1
Chung, S; Dangott, LJ; Huang, H; Kier, AB; Landrock, D; Landrock, KK; Li, S; Martin, GG; McIntosh, AL; Schroeder, F	1
Dubroeucq, MC; Imperato, A; Jeantaud, B; Petitet, F; Reibaud, M	1
Bonner, TI; Buckley, NE; Compton, DR; Járai, Z; Kunos, G; Lake, KD; Martin, BR; Mezey, E; Razdan, RK; Varga, K; Wagner, JA; Zimmer, A; Zimmer, AM	1
DeLorenzo, RJ; Martin, BR; Wallace, MJ; Wiley, JL	1
Löscher, W; Richter, A	1
Hiley, CR; Ho, WS	1
Burton, P; Kwiatkowska, M; Mechoulam, R; Parker, LA	1
Burton, P; Mechoulam, R; Parker, LA; Sorge, RE; Yakiwchuk, C	1
Colleoni, M; Costa, B; Franke, C; Giagnoni, G; Trovato, AE	1
Abe, K; Egashira, N; Fujiwara, M; Hasebe, N; Hayakawa, K; Ikeda, T; Inui, K; Iwasaki, K; Mishima, K; Takamatsu, F; Yasuda, H	1
Bariselli, F; Colombo, A; Martucci, C; Massi, P; Panerai, AE; Parolaro, D; Sacerdote, P; Vaccani, A	1
Breuer, A; Fride, E; Hanus, L; Ponde, D	1
Maor, Y; Mechoulam, R; Pertwee, RG; Stevenson, LA; Thomas, A	1
Auchampach, JA; Carrier, EJ; Hillard, CJ	1
Baillie, GL; Pertwee, RG; Phillips, AM; Razdan, RK; Ross, RA; Thomas, A	1
Abe, K; Egashira, N; Fujioka, M; Fujiwara, M; Hasebe, N; Hayakawa, K; Hazekawa, M; Iwasaki, K; Liu, AX; Mishima, K; Nozako, M; Ogata, A	1
Abe, K; Egashira, N; Fujioka, M; Fujiwara, M; Hasebe, N; Hayakawa, K; Hazekawa, M; Irie, K; Iwasaki, K; Mishima, K; Nozako, M; Orito, K	1
Aviello, G; Borrelli, F; Capasso, F; Capasso, R; Izzo, AA; Romano, B; Scalisi, C	1
Bitencourt, RM; Pamplona, FA; Takahashi, RN	1
Kawohl, W; Roser, P; Vollenweider, FX	1
Crippa, JA; Hallak, JE; Zuardi, AW	1
Ditrói, K; Kleiner, D	1
Farrimond, JA; Whalley, BJ; Williams, CM	1
Abílio, VC; Almeida, V; Calzavara, MB; Crippa, JA; da Silva, ND; Hallak, JE; Levin, R; Niigaki, ST; Peres, FF; Suiama, MA; Zuardi, AW	1
Haussleiter, IS; Roser, P	1
Dashney, B; Limebeer, CL; O'Brien, LD; Parker, LA; Rock, EM; Segsworth, B; Wills, KL	1
Aguiar, DC; Campos, AC; Díaz-Alonso, J; Fogaça, MV; Galve-Roperh, I; Guimarães, FS; Guzmán, M; Moreira, FA; Ortega, Z; Ortega-Gutiérrez, S; Palazuelos, J; Vázquez-Villa, H	1
Bitencourt, RM; Do Monte, FH; Kroon, JA; Souza, RR; Takahashi, RN	1
Bondarenko, AI	1
Creehan, KM; Taffe, MA; Vandewater, SA	1
Carrillo-Salinas, FJ; de Lago, E; Espejo-Porras, F; Feliú, A; Fernández-Ruiz, J; Guaza, C; Mecha, M; Moreno-Martet, M	1
McMahon, LR	1
Angus, JA; Mazeh, AC; Wright, CE	1
Bifulco, M; Fiore, D; Gazzerro, P; Proto, MC	1

Reviews

5 review(s) available for sr141716 and cannabidiol

Article	Year
Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:2 Pt 2 Topics: Animals; Antipsychotic Agents; Arachidonic Acids; Cannabidiol; Endocannabinoids; Humans; Memory; Piperidines; Polyunsaturated Alkamides; Proto-Oncogene Proteins c-fos; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Schizophrenia; Sensory Gating	2010
[Therapeutical use of the cannabinoids in psychiatry]. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2010, Volume: 32 Suppl 1 Topics: Animals; Cannabidiol; Dronabinol; Humans; Mental Disorders; Piperidines; Psychotropic Drugs; Pyrazoles; Rimonabant	2010
[The potential use of cannabidiol in the therapy of metabolic syndrome]. Orvosi hetilap, 2012, Apr-01, Volume: 153, Issue:13 Topics: Adipocytes; Appetite Depressants; Atherosclerosis; Cannabidiol; Cannabinoid Receptor Antagonists; Disease Progression; Humans; Hyperphagia; Ischemia; Metabolic Syndrome; Obesity; Piperidines; PPAR gamma; Pyrazoles; Rimonabant	2012
Antipsychotic-like effects of cannabidiol and rimonabant: systematic review of animal and human studies. Current pharmaceutical design, 2012, Volume: 18, Issue:32 Topics: Animals; Antipsychotic Agents; Cannabidiol; Cannabinoid Receptor Antagonists; Haplorhini; Humans; Mice; Piperidines; Pyrazoles; Rats; Rimonabant	2012
Endothelial atypical cannabinoid receptor: do we have enough evidence? British journal of pharmacology, 2014, Volume: 171, Issue:24 Topics: Anisoles; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cyclohexanes; Endothelial Cells; Humans; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Rimonabant; Vasodilation	2014

Other Studies

32 other study(ies) available for sr141716 and cannabidiol

Article	Year
A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors. Journal of medicinal chemistry, 2000, Jun-15, Volume: 43, Issue:12 Topics: Arachidonic Acids; Cannabinoids; Drug Design; Endocannabinoids; Indoles; Ligands; Models, Biological; Models, Molecular; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship	2000
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis. Journal of medicinal chemistry, 2016, 07-28, Volume: 59, Issue:14 Topics: Dose-Response Relationship, Drug; HEK293 Cells; Humans; Models, Molecular; Molecular Structure; Multiple Sclerosis; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship	2016
FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein. Biochemistry, 2016, 09-20, Volume: 55, Issue:37 Topics: Animals; Endocannabinoids; Fatty Acid-Binding Proteins; Female; Fluorescent Dyes; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Receptors, Cannabinoid	2016
Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. Life sciences, 1998, Volume: 63, Issue:1 Topics: Analgesics; Animals; Binding, Competitive; Brain; Cannabidiol; Cell Membrane; Cerebellar Cortex; Cyclohexanols; Dronabinol; Guanosine Triphosphate; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant	1998
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proceedings of the National Academy of Sciences of the United States of America, 1999, Nov-23, Volume: 96, Issue:24 Topics: Animals; Arachidonic Acids; Cannabidiol; Cannabinoids; Dronabinol; Endocannabinoids; Endothelium, Vascular; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Nitric Oxide; Piperidines; Polyunsaturated Alkamides; Potassium Channels; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Vasodilation; Vasodilator Agents	1999
Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. European journal of pharmacology, 2001, Sep-28, Volume: 428, Issue:1 Topics: Animals; Anticonvulsants; Behavior, Animal; Benzoxazines; Cannabidiol; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Electroshock; Male; Mice; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant	2001
Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia. European journal of pharmacology, 2002, Nov-15, Volume: 454, Issue:2-3 Topics: Animals; Benzoxazines; Cannabidiol; Cannabinoid Receptor Modulators; Cannabinoids; Chorea; Cricetinae; Disease Models, Animal; Dystonia; Female; Male; Mesocricetus; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant	2002
Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. British journal of pharmacology, 2003, Volume: 138, Issue:7 Topics: Animals; Calcium Channels; Calcium Chloride; Camphanes; Cannabidiol; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Endothelium-Dependent Relaxing Factors; Gap Junctions; Heterotrimeric GTP-Binding Proteins; In Vitro Techniques; Male; Mesenteric Arteries; Myography; Piperidines; Potassium Channels, Calcium-Activated; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Rimonabant; Vasodilation	2003
Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew). Psychopharmacology, 2004, Volume: 171, Issue:2 Topics: Animals; Antiemetics; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Female; Injections, Intraperitoneal; Lithium Chloride; Male; Piperidines; Pyrazoles; Rimonabant; Shrews; Vomiting	2004
Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats. Psychopharmacology, 2004, Volume: 175, Issue:3 Topics: Amphetamine; Animals; Cannabidiol; Cocaine; Conditioning, Operant; Dronabinol; Extinction, Psychological; Learning; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant	2004
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation. British journal of pharmacology, 2004, Volume: 143, Issue:2 Topics: Administration, Oral; Animals; Camphanes; Cannabidiol; Capsaicin; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Hyperalgesia; Inflammation; Italy; Male; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Drug; Rimonabant; Time Factors	2004
Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism. Neuroreport, 2004, Oct-25, Volume: 15, Issue:15 Topics: Analysis of Variance; Animals; Body Temperature; Brain Infarction; Cannabidiol; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Fever; Infarction, Middle Cerebral Artery; Male; Mice; Neuroprotective Agents; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Tetrazolium Salts; Time Factors	2004
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. Journal of neuroimmunology, 2005, Volume: 159, Issue:1-2 Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Camphanes; Cannabidiol; Cell Migration Inhibition; Cells, Cultured; Chemotaxis; Cytokines; Down-Regulation; Interleukin-10; Interleukin-12; Macrophage Activation; Macrophages, Peritoneal; Male; Mice; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Up-Regulation	2005
Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors. Neuropharmacology, 2005, Volume: 48, Issue:8 Topics: Animals; Binding, Competitive; Body Temperature; Camphanes; Cannabidiol; Capsaicin; Drug Interactions; Ear, External; Gastrointestinal Motility; Inflammation; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Motor Activity; Pain Measurement; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant	2005
Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferens. Neuropharmacology, 2005, Volume: 48, Issue:8 Topics: Adenosine Triphosphate; Adrenergic alpha-2 Receptor Antagonists; Animals; Benzoxazines; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Capsaicin; In Vitro Techniques; Isometric Contraction; Male; Mice; Morpholines; Naloxone; Naphthalenes; Phenylephrine; Piperidines; Pyrazoles; Rimonabant; Ruthenium Red; TRPV Cation Channels; Vas Deferens; Yohimbine	2005
Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proceedings of the National Academy of Sciences of the United States of America, 2006, May-16, Volume: 103, Issue:20 Topics: Adenosine; Animals; Camphanes; Cannabidiol; Cell Line; Cell Proliferation; DNA; Dronabinol; Equilibrative Nucleoside Transporter 1; Immunosuppression Therapy; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Nucleoside Transport Proteins; Piperidines; Psychotropic Drugs; Pyrazoles; Rimonabant; Thymidine; Tumor Necrosis Factor-alpha	2006
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. British journal of pharmacology, 2007, Volume: 150, Issue:5 Topics: Animals; Anti-Inflammatory Agents; Benzoxazines; Brain; Camphanes; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cell Membrane; CHO Cells; Cricetinae; Cricetulus; Cyclohexanes; Cyclohexanols; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Humans; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Naphthalenes; Phenols; Piperidines; Protein Binding; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Rimonabant; Transfection	2007
Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance. Neuropharmacology, 2007, Volume: 52, Issue:4 Topics: Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Cannabidiol; Cerebral Infarction; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Drug Interactions; Drug Tolerance; Infarction, Middle Cerebral Artery; Male; Mice; Neuroprotective Agents; Piperazines; Piperidines; Pyrazoles; Rimonabant; Serotonin Antagonists; Time Factors	2007
Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism. Journal of neurochemistry, 2007, Volume: 102, Issue:5 Topics: Animals; Behavior, Animal; Cannabidiol; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Functional Laterality; Glutamic Acid; Infarction, Middle Cerebral Artery; Male; Mice; Motor Activity; Neuroprotective Agents; Perfusion; Peroxidase; Piperidines; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Tetrazolium Salts; Time Factors	2007
Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice. British journal of pharmacology, 2008, Volume: 154, Issue:5 Topics: Acetylcholine; Amidohydrolases; Animals; Cannabidiol; Cannabis; Cholinergic Agents; Croton Oil; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gastrointestinal Agents; Gastrointestinal Motility; Gastrointestinal Transit; Ileitis; Ileum; Loperamide; Male; Mice; Mice, Inbred ICR; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant	2008
Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2008, Volume: 18, Issue:12 Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Arachidonic Acids; Behavior, Animal; Cannabidiol; Capsaicin; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Administration Schedule; Extinction, Psychological; Fear; Freezing Reaction, Cataleptic; Injections, Intraventricular; Male; Maze Learning; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant; TRPV Cation Channels	2008
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns. Psychopharmacology, 2012, Volume: 223, Issue:1 Topics: Animals; Cannabidiol; Cannabinoid Receptor Antagonists; Cannabinoids; Cannabinol; Eating; Feeding Behavior; Male; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Time Factors	2012
Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia. Current pharmaceutical design, 2012, Volume: 18, Issue:32 Topics: Animals; Cannabidiol; Cannabinoid Receptor Antagonists; Disease Models, Animal; Emotions; Male; Piperidines; Pyrazoles; Rats, Wistar; Rimonabant; Schizophrenia; Schizophrenic Psychology	2012
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. Pharmacology, biochemistry, and behavior, 2013, Volume: 103, Issue:3 Topics: Animals; Anxiety; Behavior, Animal; Cannabidiol; Cannabinoid Receptor Antagonists; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Drug Inverse Agonism; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Saccharin; Taste; Taste Perception	2013
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system. The international journal of neuropsychopharmacology, 2013, Volume: 16, Issue:6 Topics: Animals; Anti-Anxiety Agents; Bromodeoxyuridine; Camphanes; Cannabidiol; Cannabinoid Receptor Antagonists; Cell Cycle; Cell Line, Transformed; Cell Proliferation; Disease Models, Animal; Feeding Behavior; Glial Fibrillary Acidic Protein; Hippocampus; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurogenesis; Piperidines; Pyrazoles; Rimonabant; Stress, Psychological; Thymidine Kinase	2013
Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors. Behavioural brain research, 2013, Aug-01, Volume: 250 Topics: Animals; Cannabidiol; Cannabinoid Receptor Antagonists; Cerebral Cortex; Conditioning, Classical; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; Extinction, Psychological; Fear; Freezing Reaction, Cataleptic; Male; Microinjections; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant; Time Factors	2013
Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats. British journal of pharmacology, 2015, Volume: 172, Issue:7 Topics: Animals; Body Temperature; Cannabidiol; Cannabinoid Receptor Antagonists; Dronabinol; Hypothermia; Male; Motor Activity; Piperidines; Pyrazoles; Rats, Sprague-Dawley; Rimonabant; Telemetry	2015
The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors. Multiple sclerosis and related disorders, 2015, Volume: 4, Issue:6 Topics: Animals; Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Drug Combinations; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Mice, Inbred C57BL; Neuroprotective Agents; Photomicrography; Piperidines; Plant Extracts; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Spinal Cord	2015
Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys. Drug and alcohol dependence, 2016, Aug-01, Volume: 165 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cannabidiol; Conditioning, Operant; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Macaca mulatta; Male; Piperidines; Pyrazoles; Reinforcement Schedule; Rimonabant	2016
Pharmacological characterisation of the CB European journal of pharmacology, 2021, Oct-15, Volume: 909 Topics: Adenosine Triphosphate; Animals; Biological Assay; Cannabidiol; Cannabinoid Receptor Antagonists; Male; Muscle Contraction; Norepinephrine; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Vas Deferens	2021
Rimonabant and Cannabidiol Rewrite the Interactions between Breast Cancer Cells and Tumor Microenvironment. International journal of molecular sciences, 2023, Aug-30, Volume: 24, Issue:17 Topics: Breast Neoplasms; Cannabidiol; Female; Humans; Melanoma, Cutaneous Malignant; Rimonabant; Tumor Microenvironment	2023